Movement Alert｜HBM HOLDINGS-B Drops 5.03% in Regular Trading, H1 Net Profit Declines 11% Despite Revenue Growth

Market Focus08-28

On August 28, HBM HOLDINGS-B fell 5.03% in regular trading, trading at HK$15.44, with turnover of HK$53.28 million.

The decline follows the company's interim results released on August 27, which showed first-half revenue of US$122 million, up 20.9% year-over-year, but net profit of US$64.85 million, down 11.16% from the prior year period. The profit erosion was primarily driven by a 64.6% surge in R&D costs from US$17.96 million to US$29.60 million, and a 126.3% jump in administrative expenses from US$7.36 million to US$16.67 million, largely attributable to increased headcount costs and litigation-related fees.

While molecular licensing and collaboration revenue grew to US$113 million, the significant expansion on the cost side compressed margins, prompting a negative market reaction to the revenue-profit divergence pattern. The company reported an operating margin of 54% and gross margin of approximately 95.2% for the period.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1189028922?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-28 11:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189028922","market":"us","top_or_hot":-1,"title":"Movement Alert｜HBM HOLDINGS-B Drops 5.03% in Regular Trading, H1 Net Profit Declines 11% Despite Revenue Growth","media":"Market Focus","content":"<p><p>On August 28, HBM HOLDINGS-B fell 5.03% in regular trading, trading at HK$15.44, with turnover of HK$53.28 million.</p><p>The decline follows the company's interim results released on August 27, which showed first-half revenue of US$122 million, up 20.9% year-over-year, but net profit of US$64.85 million, down 11.16% from the prior year period. The profit erosion was primarily driven by a 64.6% surge in R&D costs from US$17.96 million to US$29.60 million, and a 126.3% jump in administrative expenses from US$7.36 million to US$16.67 million, largely attributable to increased headcount costs and litigation-related fees.</p><p>While molecular licensing and collaboration revenue grew to US$113 million, the significant expansion on the cost side compressed margins, prompting a negative market reaction to the revenue-profit divergence pattern. The company reported an operating margin of 54% and gross margin of approximately 95.2% for the period.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜HBM HOLDINGS-B Drops 5.03% in Regular Trading, H1 Net Profit Declines 11% Despite Revenue Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜HBM HOLDINGS-B Drops 5.03% in Regular Trading, H1 Net Profit Declines 11% Despite Revenue Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-28 11:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 28, HBM HOLDINGS-B fell 5.03% in regular trading, trading at HK$15.44, with turnover of HK$53.28 million.</p><p>The decline follows the company's interim results released on August 27, which showed first-half revenue of US$122 million, up 20.9% year-over-year, but net profit of US$64.85 million, down 11.16% from the prior year period. The profit erosion was primarily driven by a 64.6% surge in R&D costs from US$17.96 million to US$29.60 million, and a 126.3% jump in administrative expenses from US$7.36 million to US$16.67 million, largely attributable to increased headcount costs and litigation-related fees.</p><p>While molecular licensing and collaboration revenue grew to US$113 million, the significant expansion on the cost side compressed margins, prompting a negative market reaction to the revenue-profit divergence pattern. The company reported an operating margin of 54% and gross margin of approximately 95.2% for the period.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02142","symbol_name":"和铂医药-B","start_time":0,"source_url":"","article_id":"1189028922","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189028922","pubTimestamp":1787886267,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 28, HBM HOLDINGS-B fell 5.03% in regular trading, trading at HK$15.44, with turnover of HK$53.28 million.The decline follows the company's interim results released on August 27, which...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02142":"和铂医药-B"},"translate_title":"变动警报|HBM HOLDINGS-B 常规交易下跌 5.03%，尽管收入增长，上半年净利润仍下降 11%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02142":1},"content_text":"On August 28, HBM HOLDINGS-B fell 5.03% in regular trading, trading at HK$15.44, with turnover of HK$53.28 million.The decline follows the company's interim results released on August 27, which showed first-half revenue of US$122 million, up 20.9% year-over-year, but net profit of US$64.85 million, down 11.16% from the prior year period. The profit erosion was primarily driven by a 64.6% surge in R&D costs from US$17.96 million to US$29.60 million, and a 126.3% jump in administrative expenses from US$7.36 million to US$16.67 million, largely attributable to increased headcount costs and litigation-related fees.While molecular licensing and collaboration revenue grew to US$113 million, the significant expansion on the cost side compressed margins, prompting a negative market reaction to the revenue-profit divergence pattern. The company reported an operating margin of 54% and gross margin of approximately 95.2% for the period.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1189028922","isCrawlerRequest":true}